Cardlytics (NASDAQ:CDLX) Posts Earnings Results, Misses Estimates By $0.07 EPS

Cardlytics (NASDAQ:CDLXGet Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.07), Zacks reports. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. Cardlytics updated its Q1 2025 guidance to EPS.

Cardlytics Price Performance

CDLX traded down $0.04 on Wednesday, hitting $1.98. 1,819,490 shares of the company’s stock traded hands, compared to its average volume of 997,723. The company’s 50 day simple moving average is $3.09 and its 200-day simple moving average is $3.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics has a one year low of $1.77 and a one year high of $20.52. The firm has a market cap of $100.63 million, a price-to-earnings ratio of -0.32 and a beta of 1.62.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $6.92.

Read Our Latest Stock Report on CDLX

Insiders Place Their Bets

In related news, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares of the company’s stock, valued at approximately $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the transaction, the chief executive officer now owns 418,637 shares of the company’s stock, valued at $1,423,365.80. This represents a 10.07 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 111,454 shares of company stock worth $391,864 in the last three months. 4.40% of the stock is owned by company insiders.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.